193 related articles for article (PubMed ID: 35432717)
21. Role of GRB2-associated binder 1 in epidermal growth factor receptor-induced signaling in head and neck squamous cell carcinoma.
Hoeben A; Martin D; Clement PM; Cools J; Gutkind JS
Int J Cancer; 2013 Mar; 132(5):1042-50. PubMed ID: 22865653
[TBL] [Abstract][Full Text] [Related]
22. Ferroptosis promotes anti-tumor immune response by inducing immunogenic exposure in HNSCC.
Zhao YY; Lian JX; Lan Z; Zou KL; Wang WM; Yu GT
Oral Dis; 2023 Apr; 29(3):933-941. PubMed ID: 34773344
[TBL] [Abstract][Full Text] [Related]
23. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
[TBL] [Abstract][Full Text] [Related]
24. EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy.
Liu S; Wang Y; Han Y; Xia W; Zhang L; Xu S; Ju H; Zhang X; Ren G; Liu L; Ye W; Zhang Z; Hu J
Theranostics; 2020; 10(23):10589-10605. PubMed ID: 32929368
[No Abstract] [Full Text] [Related]
25. Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis.
Savic D; Steinbichler TB; Ingruber J; Negro G; Aschenbrenner B; Riechelmann H; Ganswindt U; Skvortsov S; Dudás J; Skvortsova II
Cells; 2023 Jan; 12(2):. PubMed ID: 36672272
[TBL] [Abstract][Full Text] [Related]
26. Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells.
Erjala K; Sundvall M; Junttila TT; Zhang N; Savisalo M; Mali P; Kulmala J; Pulkkinen J; Grenman R; Elenius K
Clin Cancer Res; 2006 Jul; 12(13):4103-11. PubMed ID: 16818711
[TBL] [Abstract][Full Text] [Related]
27. The role of ferroptosis in radiotherapy and combination therapy for head and neck squamous cell carcinoma (Review).
Feng Y; Li X; Yang B; Li M; Du Y; Wang J; Liu S; Gong L; Li L; Gao L
Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38639185
[TBL] [Abstract][Full Text] [Related]
28. A novel intronic circular RNA, circGNG7, inhibits head and neck squamous cell carcinoma progression by blocking the phosphorylation of heat shock protein 27 at Ser78 and Ser82.
Ju H; Hu Z; Wei D; Huang J; Zhang X; Rui M; Li Z; Zhang X; Hu J; Guo W; Ren G
Cancer Commun (Lond); 2021 Nov; 41(11):1152-1172. PubMed ID: 34498800
[TBL] [Abstract][Full Text] [Related]
29. Hippo pathway effectors YAP/TAZ as novel determinants of ferroptosis.
Yang WH; Chi JT
Mol Cell Oncol; 2020; 7(1):1699375. PubMed ID: 31993503
[TBL] [Abstract][Full Text] [Related]
30. ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibition.
Ruicci KM; Pinto N; Khan MI; Yoo J; Fung K; MacNeil D; Mymryk JS; Barrett JW; Nichols AC
Oral Oncol; 2018 Sep; 84():95-103. PubMed ID: 30115483
[TBL] [Abstract][Full Text] [Related]
31. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
[TBL] [Abstract][Full Text] [Related]
32. Loss of TP63 Promotes the Metastasis of Head and Neck Squamous Cell Carcinoma by Activating MAPK and STAT3 Signaling.
Lakshmanachetty S; Balaiya V; High WA; Koster MI
Mol Cancer Res; 2019 Jun; 17(6):1279-1293. PubMed ID: 30910837
[TBL] [Abstract][Full Text] [Related]
33. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.
Jing C; Duan Y; Zhou M; Yue K; Zhuo S; Li X; Liu D; Ye B; Lai Q; Li L; Yao X; Wei H; Zhang W; Wu Y; Wang X
Theranostics; 2021; 11(6):2655-2669. PubMed ID: 33456565
[TBL] [Abstract][Full Text] [Related]
34. [Construction of epithelial membrane protein 1 eukaryotic expression vector and its influence on migration and invasion of human oral tongue squamous carcinoma cells].
Xiaohua D; Jun Z; Huiru Z; Xiaoli L; Yanni L; Guanhua W; Yan Y
Hua Xi Kou Qiang Yi Xue Za Zhi; 2016 Aug; 34(4):398-403. PubMed ID: 28317360
[TBL] [Abstract][Full Text] [Related]
35. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
Tang YC; Hsiao JR; Jiang SS; Chang JY; Chu PY; Liu KJ; Fang HL; Lin LM; Chen HH; Huang YW; Chen YT; Tsai FY; Lin SF; Chuang YJ; Kuo CC
Theranostics; 2021; 11(11):5232-5247. PubMed ID: 33859744
[No Abstract] [Full Text] [Related]
36. UBE2C promotes the progression of head and neck squamous cell carcinoma.
Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma.
He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H
Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150
[TBL] [Abstract][Full Text] [Related]
38. Epithelial membrane protein 1 promotes tumor metastasis by enhancing cell migration via copine-III and Rac1.
Ahmat Amin MKB; Shimizu A; Zankov DP; Sato A; Kurita S; Ito M; Maeda T; Yoshida T; Sakaue T; Higashiyama S; Kawauchi A; Ogita H
Oncogene; 2018 Oct; 37(40):5416-5434. PubMed ID: 29867202
[TBL] [Abstract][Full Text] [Related]
39. A Novel Ferroptosis-Related Gene Signature to Predict Prognosis in Patients with Head and Neck Squamous Cell Carcinoma.
Xu L; Li YY; Zhang YC; Wu YX; Guo DD; Long D; Liu ZH
Dis Markers; 2021; 2021():5759927. PubMed ID: 34853622
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of secreted phosphoprotein 1 affects malignant progression, prognosis, and resistance to cetuximab via the KRAS/MEK pathway in head and neck cancer.
Liu K; Hu H; Jiang H; Liu C; Zhang H; Gong S; Wei D; Yu Z
Mol Carcinog; 2020 Oct; 59(10):1147-1158. PubMed ID: 32805066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
